SEQUANTRIX Launches Operations

SEQUANTRIX signs agreement with Chugai to use the AI-driven Disease­Decoder for drug development

SEQUANTRIX signs agreement with argenx to use the AI-driven Disease­Decoder and advanced animal models for drug development